Thursday, January 19, 2023 4:03:03 PM
Many Penny Stock "Investors" just don't have the patience to wait it out! Some of the younger people want riches immediately, showing their inexperience in this field! People have to understand & accept the fact that there are far more downs than ups, and that each P-Stock takes quite few years before it blossoms, if it Blossoms at all! Let's emphasize to them, from a factual basis, is that over 90 % of sub-penny stocks fail to make it to the Clinical stages, not to mention the Commercial end of it?
This sector of stocks requires more waiting time than other sectors, so newer Investors, make sure your Belt is on tight, for the ride is a tough and exhausting journey to the end, whatever direction that might be!
Rgbp has many things going for it, but to date the PPS slippage is due to the understandable lack of positive signs the Co' is PRing? They themselves know little as progress in the Clinical trials usually means little until the end of the trials, which take from 1 to 4/5 years? Yes, we could use some encouraging words, but they will come out when the trials conclude, not sooner! Yes SV, their thought Errors or misconceptions force them to leave early, but they have to know from experienced people like you is that this Co' has novel, if not REVOLUTIONARY ways to treat major diseases, and that means a lot more testing before we know more! Yes, this stock is speculative, but has passed many hurdles already, showing that they are legitimate & the CEO forthright!
This sector of stocks requires more waiting time than other sectors, so newer Investors, make sure your Belt is on tight, for the ride is a tough and exhausting journey to the end, whatever direction that might be!
Rgbp has many things going for it, but to date the PPS slippage is due to the understandable lack of positive signs the Co' is PRing? They themselves know little as progress in the Clinical trials usually means little until the end of the trials, which take from 1 to 4/5 years? Yes, we could use some encouraging words, but they will come out when the trials conclude, not sooner! Yes SV, their thought Errors or misconceptions force them to leave early, but they have to know from experienced people like you is that this Co' has novel, if not REVOLUTIONARY ways to treat major diseases, and that means a lot more testing before we know more! Yes, this stock is speculative, but has passed many hurdles already, showing that they are legitimate & the CEO forthright!
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
